About Epify

About company

Epify was founded when a collaboration between Maastricht University and the bioinformatics group of Ghent University identified a need for their knowledge of epigenetic biomarkers to be translated into care for cancer patients. Epify will combine the scientific expertise from these institutions with a sound business knowledge to create industrial applications that ensure the biomarkers are used to their full potential and are made accessible to patients and clinicians.